Coq10 and Flushing aggravated - a phase IV clinical study of FDA data
Flushing aggravated is found among people who take Coq10, especially for people who are male, 60+ old.
The phase IV clinical study analyzes which people take Coq10 and have Flushing aggravated. It is created by eHealthMe based on reports of 9,057 people who have side effects when taking Coq10 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
9,057 people reported to have side effects when taking Coq10.
Among them, 438 people (4.84%) have Flushing aggravated.
What is Coq10?
Coq10 has active ingredients of coenzyme q - 10. It is often used in high blood cholesterol. eHealthMe is studying from 10,028 Coq10 users for its effectiveness, alternative drugs and more.
What is Flushing aggravated?
Flushing aggravated (worse the warm, red condition of human skin) is found to be associated with 967 drugs and 347 conditions by eHealthMe.
Number of Coq10 and Flushing aggravated reports submitted per year:
Gender of people who have Flushing aggravated when taking Coq10*:
Age of people who have Flushing aggravated when taking Coq10 *:
Common drugs people take besides Coq10 *:
Common side effects people have besides Flushing aggravated *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Coq10 and have Flushing aggravated?Check whether Flushing aggravated is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Peel MM, Cooke M, Lewis-Peel HJ, Lea RA, Moyle W, "A randomized controlled trial of coenzyme Q 10 for fatigue in the late-onset sequelae of poliomyelitis", Complementary therapies in medicine, 2015 Dec .
How severe was Flushing aggravated and when was it recovered:
Expand to all the drugs that have ingredients of coenzyme q - 10:
Alternative drugs to, pros and cons of Coq10:
- Coq10 (10,028 reports)
Common Coq10 side effects:
- Fatigue (feeling of tiredness): 918 reports
- Weakness: 648 reports
- Dizziness: 620 reports
- Headache (pain in head): 602 reports
- Drug ineffective: 557 reports
- Pain: 551 reports
- Diarrhea: 548 reports
Browse all side effects of Coq10:a b c d e f g h i j k l m n o p q r s t u v w x y z
Flushing aggravated treatments and more:
- Flushing aggravated (32 reports)
COVID vaccines that are related to Flushing aggravated:
- Flushing aggravated in Moderna COVID Vaccine
- Flushing aggravated in Pfizer BioNTech Covid Vaccine
- Flushing aggravated in Johnson and Johnson Covid Vaccine
Common drugs associated with Flushing aggravated:
- Niaspan: 18,897 reports
- Tecfidera: 18,304 reports
- Aspirin: 9,030 reports
- Simcor: 5,358 reports
- Lisinopril: 3,923 reports
- Fish oil: 3,195 reports
- Metformin: 3,096 reports
- Prednisone: 3,006 reports
- Benadryl: 2,801 reports
- Vitamin d: 2,777 reports
All the drugs that are associated with Flushing aggravated:
- Flushing aggravated (967 drugs)
Common conditions associated with Flushing aggravated:
- Multiple sclerosis: 20,241 reports
- High blood cholesterol: 11,039 reports
- High blood pressure: 3,086 reports
- Rheumatoid arthritis: 1,930 reports
All the conditions that are associated with Flushing aggravated:
- Flushing aggravated (347 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on coenzyme q - 10 (the active ingredients of Coq10) and Coq10 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Losartan Potassium And Hydrochlorothiazide vs. Synthroid - now
- Lopressor vs. Niacin - 3 seconds ago
- Symbicort and Speech Impairment (Adult) - 5 seconds ago
- Loryna vs. Lo Loestrin Fe - 15 seconds ago
- Lipitor and Relpax drug interaction - 24 seconds ago
- Bextra and Cubital Tunnel Syndrome - 25 seconds ago
- Maxzide vs. Lopressor Hct - 27 seconds ago
- Lortab and Baclofen drug interaction - 28 seconds ago
- Anastrozole and Psoriatic Arthropathy Aggravated - 29 seconds ago
- Lodine vs. Nitrous Oxide W/ Oxygen - 32 seconds ago